Four IPOs are scheduled for the week of March 25th. The full IPO calendar here.
Based in New York, NY, Garrison Capital (GARS) scheduled an $80 million IPO with a market capitalization of $240 at a price range mid-point of $15 for Wednesday, March 27, 2013.
GARS is a Business Development Investment Corp retread that was originally scheduled for October 11, 2011. Then is was scheduled to yield 7.75%. Based on the new SEC filing its indicated payout is 7.55% maximum based on recent financials.
Cancer Genetics (CGIX)
Based in Rutherford, NJ, Cancer Genetics scheduled a $6.6 million IPO with a market capitalization of $44 million at a price range mid-point of $11, for Thursday, March 28, 2013.
CBIX had scheduled an IPO for the week Wednesday, February 13, 2013 but it was postponed.
CBIX is an early-stage diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve and personalize the diagnosis, prognosis and response to treatment (theranosis) of cancer.
Pinnacle Foods (PF)
Based in Parsippany, NJ, Pinnacle Foods scheduled a $551 million IPO with a market capitalization of $2.15 billion at a price range mid-point of $19 for Thursday, March 28, 2013.
PF has three divisions: Birds Eye Frozen Foods, Duncan Hines Grocery, and Speciality Foods. Sales for the last three years have been flat, in the $2.4 billion plus range. Gross profit is down 5% for 2012 vs 2011, but adjusted net profit is up to $113 million from $60 million.
Based in Hollywood, FL, NV5 Holdings (NVEE) scheduled a $6 million IPO with a market capitalization of $22 million at a price range mid-point of $6, for the week of March 25th, 2013. NVEE is a hold-over from last week.
NVEE is a small engineering & consulting company heavily dependent on the public sector.